METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is characterized by its insensitivity to chemoradiotherapy and lacks effective diagnostic and prognostic biomarkers. In this study, we focused on the role of m6A RNA methylation regulators for tumor immunity. Based on the expression of 20 m6A regulators, conse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Genet
Main Authors: Xu, Tianbo, Gao, Su, Ruan, Hailong, Liu, Jingchong, Liu, Yuenan, Liu, Di, Tong, Junwei, Shi, Jian, Yang, Hongmei, Chen, Ke, Zhang, Xiaoping
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Genetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8194313/
https://ncbi.nlm.nih.gov/pubmed/34122497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.609174
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados